[Management of a global health crisis: first COVID-19 disease feedback from Overseas and French-speaking countries medical biologists].
Barguil Y, Chiaradia L, Sicard D, Duhin M, Sebat C, Abdi S, Alomar Y, Blondeel N, Bonnet C, Bouberi-Niava B, Bourgoin-Rousset E, Cavalier E, Cisse F, Combe P, de Guire V, Devaud F, De Wulf A, Agne FD, Dumas-Chastang E, Ecrabey YC, Grignon JC, Gruson D, Gueye PM, Hayette MP, Kabré E, Kandji PM, Kouakou HF, Legris-Allusson V, Lim S, Monde A, Monnet D, Forton GN, Outreville J, Padelli M, Sakandé J, Sall A, Subiros M, Tayeb N, Temmar A, Thiam S, Ting Wang H, Bérard AM, Piéroni L, Sapin V, Beauvieux MC; Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 ».
Barguil Y, et al.
Ann Biol Clin (Paris). 2020 Oct 1;78(5):499-518. doi: 10.1684/abc.2020.1586.
Ann Biol Clin (Paris). 2020.
PMID: 33026346
Free article.
French.
The French society of clinical biology "Biochemical markers of COVID-19" has set up a working group with the primary aim of reviewing, analyzing and monitoring the evolution of biological prescriptions according to the patient's care path and to look for markers of …
The French society of clinical biology "Biochemical markers of COVID-19" has set up a working group with the primary aim of re …